DEXCOM INC 4
4 · DEXCOM INC · Filed Mar 10, 2017
Insider Transaction Report
Form 4
DEXCOM INCDXCM
GREGG TERRANCE H
DirectorPresident & CEO
Transactions
- Disposition to Issuer
Common Stock
2017-03-10$77.55/sh−1,661$128,812→ 469,071 total - Disposition to Issuer
Common Stock
2017-03-10$77.55/sh−14,512$1,125,414→ 454,559 total - Award
Common Stock
2017-03-08$0.00/sh+30,887$31→ 470,732 total
Holdings
- 11,461(indirect: By IRA)
Common Stock
- 55,882(indirect: By Trust)
Common Stock
Footnotes (4)
- [F1]Represents a grant of restricted stock units that are exempt from Section 16 b-3 and are subject to vesting over a 36 month period from the date of grant as follows: 1/3 shall vest 12 months from the Grant Date, and the remaining balance shall vest in four equal installments over the following 24 months. Share units represent a contingent right to receive one share of DexCom, Inc. common stock.
- [F2]Included in this number are 30,877 unvested restricted stock units which were granted on March 8, 2017 and shall vest on March 8, 2018.
- [F3]These shares were sold to cover the Company's tax withholding obligation that accrued in connection with the vesting of restricted stock units previously granted.
- [F4]Shares are held by the Gregg Family Trust U/A/D 12/23/1998, with respect to which the reporting person is a trustee.